Wound-Healing Product Jurisdiction To Be Challenged At June FDA Hearing
This article was originally published in The Gray Sheet
Executive Summary
FDA is considering whether to reassign primary jurisdiction of certain tissue-based products, such as interactive wound dressings, to the Center for Biologics Evaluation & Research